An enhanced hTERT promoter-driven CRISPR/Cas9 system selectively inhibits the progression of bladder cancer cells

Mol. BioSyst., 2017, Accepted Manuscript DOI: 10.1039/C7MB00354D, PaperXinbo Huang, Chengle Zhuang, Changshui Zhuang, Tiefu Xiong, Yawen Li, Yaoting Gui The current therapies in treating tumors are lack of efficacy and specificity. Synthetic biology principles may bring some new possible methods to cure cancer. Here we present a synthetic logic... The content of this RSS Feed (c) The Royal Society of Chemistry

http://feeds.rsc.org/~r/rss/MB/~3/K0uf8M5nm8s/C7MB00354D

Source: RSC - Molecular Biosystems - June 30, 2017 Category: Molecular Biology Authors: Xinbo Huang Source Type: research